This inventor holds 2 USPTO granted patents. Top assignee: Wockhardt Limited. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Abraham Thomas: Innovator in Antibacterial Compounds
Introduction
Abraham Thomas is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 2 patents to his name, his work focuses on innovative solutions for treating bacterial infections.
Latest Patents
Abraham Thomas's latest patents include the invention of antibacterial optically pure benzoquinolizine carboxylic acids. These compounds are designed to be substantially free of their R-(+)-isomers. The invention encompasses processes for the preparation of these optically pure compounds, as well as pharmaceutical compositions that include them. The applications of these compounds are extensive, as they can be used to treat various bacterial infections, including those caused by resistant Gram-positive organisms, Gram-negative organisms, and mycobacteria. This innovation aims to avoid the toxic effects associated with the administration of racemic mixtures.
Career Highlights
Abraham Thomas is currently associated with Wockhardt Limited, a prominent pharmaceutical company. His work at Wockhardt has allowed him to focus on the development of advanced antibacterial treatments. His contributions have been instrumental in addressing the challenges posed by resistant bacterial strains.
Collaborations
Abraham has collaborated with notable colleagues such as Mahesh Vithalbhai Patel and Shivkumar Agarwal. These collaborations have further enhanced the research and development efforts in the field of antibacterial compounds.
Conclusion
Abraham Thomas stands out as an innovative inventor in the pharmaceutical industry, particularly in the development of antibacterial treatments. His work continues to have a significant impact on the fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
